Editorial
Volume: 5 | Issue: 2 | Published: Nov 05, 2022 | Pages: 059 - 060 | DOI: 10.24911/JBCGenetics/183-1653668216
Vosoritide: a drug providing a promising avenue for the treatment of short stature in children with achondroplasia
Authors: Amsal Qureshi , Areesha Moiz Alvi
Article Info
Authors
Amsal Qureshi
Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan
Areesha Moiz Alvi
Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan.
Publication History
Received: May 27, 2022
Revised: July 09, 2022
Accepted: October 16, 2022
Published: November 05, 2022
Abstract
Not available
Keywords: Achondroplasia, Vosoritide, FGFR3, children, CNP
Pubmed Style
Amsal Qureshi, Areesha Moiz Alvi. Vosoritide: a drug providing a promising avenue for the treatment of short stature in children with achondroplasia. JBC Genetics. 2022; 05 (November 2022): 059-060. doi:10.24911/JBCGenetics/183-1653668216
Web Style
Amsal Qureshi, Areesha Moiz Alvi. Vosoritide: a drug providing a promising avenue for the treatment of short stature in children with achondroplasia. https://www.jbcgenetics.com/articles/2110 [Access: April 27, 2025]. doi:10.24911/JBCGenetics/183-1653668216
AMA (American Medical Association) Style
Amsal Qureshi, Areesha Moiz Alvi. Vosoritide: a drug providing a promising avenue for the treatment of short stature in children with achondroplasia. JBC Genetics. 2022; 05 (November 2022): 059-060. doi:10.24911/JBCGenetics/183-1653668216
Vancouver/ICMJE Style
Amsal Qureshi, Areesha Moiz Alvi. Vosoritide: a drug providing a promising avenue for the treatment of short stature in children with achondroplasia. JBC Genetics. (2022), [cited April 27, 2025]; 05 (November 2022): 059-060. doi:10.24911/JBCGenetics/183-1653668216
Harvard Style
Amsal Qureshi, Areesha Moiz Alvi (2022) Vosoritide: a drug providing a promising avenue for the treatment of short stature in children with achondroplasia. JBC Genetics, 05 (November 2022): 059-060. doi:10.24911/JBCGenetics/183-1653668216
Chicago Style
Amsal Qureshi, Areesha Moiz Alvi. "Vosoritide: a drug providing a promising avenue for the treatment of short stature in children with achondroplasia." 05 (2022), 059-060. doi:10.24911/JBCGenetics/183-1653668216
MLA (The Modern Language Association) Style
Amsal Qureshi, Areesha Moiz Alvi. "Vosoritide: a drug providing a promising avenue for the treatment of short stature in children with achondroplasia." 05.November 2022 (2022), 059-060. Print. doi:10.24911/JBCGenetics/183-1653668216
APA (American Psychological Association) Style
Amsal Qureshi, Areesha Moiz Alvi (2022) Vosoritide: a drug providing a promising avenue for the treatment of short stature in children with achondroplasia. , 05 (November 2022), 059-060. doi:10.24911/JBCGenetics/183-1653668216